- List
- By Topic
- On Map
- Search Details

TPI | Recruiting, Not yet recruiting, Available Studies
Need help? See RSS Feeds
Choose a feed type:

TPI | Recruiting, Not yet recruiting, Available Studies (11 records)
Need help? See Downloading Content for Analysis
For Advanced Users: Full Study Record XML Download
1 | NCT03202927 | Recruiting | Comparative Immunogenicity Study Comparing TPI-120 to Neulasta® in Healthy Adult Subjects |
|
|
Interventional | Phase 1 |
|
Industry |
|
|
102 | All | 19 Years to 55 Years (Adult) | NCT03202927 | ADL-CL-112 | TPI-120 | March 25, 2017 | July 15, 2017 | August 22, 2017 | June 29, 2017 | July 2, 2017 |
|
|
2 | NCT03206229 | Recruiting | Study Comparing TPI-120 and Neulasta Administered Through Subcutaneous Route in Healthy Adult Subjects |
|
|
Interventional | Phase 1 |
|
Industry / Other |
|
|
122 | All | 19 Years to 55 Years (Adult) | NCT03206229 | TPI-CL-109-A | TPI-120 | February 13, 2017 | July 20, 2017 | September 30, 2017 | July 2, 2017 | July 2, 2017 |
|
|
3 | NCT03028012 | Recruiting | TPI Medication Comparison - Ketorolac, Lidocaine, or Dexamethasone |
|
|
Interventional | Phase 4 |
|
Other |
|
|
90 | All | 18 Years to 100 Years (Adult, Senior) | NCT03028012 | 98370 | May 2, 2017 | February 20, 2018 | March 20, 2018 | January 23, 2017 | June 22, 2017 |
|
||
4 | NCT01906944 | Recruiting | Ultrasound Guided Transversus Abdominis Plane (TAP) vs. Trigger Point Injection (TPI) for Abdominal Wall Pain |
|
|
Interventional | Phase 2 |
|
Other |
|
|
60 | All | 18 Years and older (Adult, Senior) | NCT01906944 | 11-004223 | January 2012 | June 2018 | June 2018 | July 24, 2013 | October 19, 2017 |
|
||
5 | NCT03278106 | Recruiting | TAS-102 in Treating Advanced Biliary Tract Cancers |
|
|
Interventional | Phase 2 |
|
Other / NIH |
|
|
28 | All | 18 Years and older (Adult, Senior) | NCT03278106 | MC1642 NCI-2017-01603 P30CA015083 |
October 20, 2017 | September 15, 2020 | September 15, 2020 | September 11, 2017 | October 25, 2017 |
|
||
6 | NCT03470025 | Recruiting | Improving Psychosocial Well-being in COPD Patients in Rehabilitation |
|
|
Interventional | Not Applicable |
|
Other |
|
|
36 | All | Child, Adult, Senior | NCT03470025 | 22/17 | IMPROVE | January 10, 2018 | June 30, 2018 | December 31, 2018 | March 19, 2018 | March 19, 2018 |
|
|
7 | NCT02301117 | Recruiting | A Phase I Study of TAS-102 in Patients With Advanced Solid Tumors With Renal Impairment |
|
|
Interventional | Phase 1 |
|
Industry |
|
|
48 | All | 18 Years and older (Adult, Senior) | NCT02301117 | TO-TAS-102-107 | January 2015 | November 2017 | November 2017 | November 25, 2014 | September 6, 2017 |
|
||
8 | NCT03365674 | Recruiting | Vibration for Pain Reduction During Trigger Point Injection |
|
|
Interventional | Not Applicable |
|
Other |
|
|
60 | All | 20 Years and older (Adult, Senior) | NCT03365674 | TPI vibrator | September 30, 2017 | June 30, 2018 | September 30, 2018 | December 7, 2017 | December 7, 2017 |
|
||
9 | NCT03298984 | Recruiting | Ph I Study of Alvocidib and Cytarabine/Daunorubicin (7+3) in Patients With Newly Diagnosed Acute Myeloid Leukemia (AML). |
|
|
Interventional | Phase 1 |
|
Industry |
|
|
25 | All | 18 Years to 65 Years (Adult) | NCT03298984 | TPI-ALV-101 | September 25, 2017 | April 2019 | October 2019 | October 2, 2017 | January 16, 2018 |
|
||
10 | NCT02520011 | Recruiting | Alvocidib Biomarker-driven Phase 2 AML Study |
|
|
Interventional | Phase 2 |
|
Industry |
|
|
119 | All | 18 Years to 65 Years (Adult) | NCT02520011 | TPI-ALV-201 | March 14, 2016 | June 2018 | December 2019 | August 11, 2015 | January 16, 2018 |
|
||
11 | NCT02602327 | Recruiting | Tas-102 and Radioembolization With 90Y Resin Microspheres for Chemo-refractory Colorectal Liver Metastases |
|
|
Interventional | Phase 1 |
|
Other |
|
|
24 | All | 18 Years and older (Adult, Senior) | NCT02602327 | Tas-102 with Radioembolization | October 2016 | September 2019 | September 2020 | November 11, 2015 | December 5, 2016 |
|
† Study has passed its completion date and status has not been verified in more than two years.